Description
The U.S. Food and Drug Administration (FDA) is seeking information from small business sources capable of providing a Preventive Maintenance and unlimited repair agreement for three Illumina NextSeq 2000 instruments. The agreement will include one scheduled on-site planned preventive maintenance visit per year, unlimited on-site corrective maintenance/repairs within 3 business days, and certified Original Equipment Manufacturer (OEM) parts for all repairs and maintenance. The contract will have a base period plus four possible one-year option years.
• The contractor must provide priority response time (within 24 hours) after initial receipt of service call.
• The contractor must provide access to OEM technical developments and unlimited OEM system software, firmware, and hardware support and updates.
• The contractor must have experience servicing Illumina NextSeq 2000 instruments.
• The contractor must provide sufficient technical information to demonstrate that the offered services meet the technical requirements.
• The contractor must provide informational pricing for the service for market research purposes.